Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,111–1,120 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1111
- Medicine slug
- norethindrone
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 30
- Source count
- 12
- Agreement rate
- 1
- Recorded readings
1 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 12
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 12 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b87cef0-610c-469d-92ba-4007f4bc3878 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9f00a3e-c827-4066-bf85-079b3a20f25e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Figure 1: Mean ± SD Norethindrone Plasma Concentrations Following Lyleq Administration Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e9f61a1-93ff-291a-bea8-9307a3b0378e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35b5ddb5-1729-4588-b2a2-ead56d78b6f9 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Figure 1: Mean ± SD Norethindrone Plasma Concentrations Following HEATHER Administration Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426ac898-7745-4645-bf9b-bae319e260e8 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af851d82-b30f-463b-9dba-0437225dc1ee (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbd54f1e-2d48-4efa-a57e-7fa7b478c457 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59985565-af09-21ba-0336-3f6db7711bd1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:121fbf86-1d76-4579-be2f-be9a957b23ab (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70231aa1-9dd2-420f-9cb3-432d3c2477d1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a786be85-49ba-4369-b510-7dccc10f7f18 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec64ec8-fbc9-440d-9838-654a605d57da (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Peak plasma concentrations occur approximately 1 hour after administration (mean T max 1.2 hours).
Projected row 1112
- Medicine slug
- norethindrone
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 30
- Source count
- 20
- Agreement rate
- 1
- Recorded readings
4 L/kg
- Numeric value
- 4
- Unit
- L/kg
- Source records
- 20
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 20 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b87cef0-610c-469d-92ba-4007f4bc3878 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9f00a3e-c827-4066-bf85-079b3a20f25e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e9f61a1-93ff-291a-bea8-9307a3b0378e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35b5ddb5-1729-4588-b2a2-ead56d78b6f9 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426ac898-7745-4645-bf9b-bae319e260e8 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26130af6-221b-2349-81b6-0c0132d6e524 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af851d82-b30f-463b-9dba-0437225dc1ee (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbd54f1e-2d48-4efa-a57e-7fa7b478c457 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59985565-af09-21ba-0336-3f6db7711bd1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:64cb920c-36e8-4d62-9d08-3ddf3989d313 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73f9807-4af6-4faa-ba9a-656a47a4c5e0 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb0b80e0-5b69-4efa-ae8a-62e718a62dc3 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bb29135-6e9b-a9e2-e063-6394a90ae9e4 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:121fbf86-1d76-4579-be2f-be9a957b23ab (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:827c7ef1-a8b7-d0c4-b062-c5154b331a35 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70231aa1-9dd2-420f-9cb3-432d3c2477d1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a786be85-49ba-4369-b510-7dccc10f7f18 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec64ec8-fbc9-440d-9838-654a605d57da (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is approximately 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f39b608-cc62-4ff0-a52a-bc3343275269 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a94321-eb60-4aa6-a429-f0156f9f8e01 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Volume of distribution of norethindrone is about 4 L/kg.
Projected row 1113
- Medicine slug
- octreotide
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 17
- Source count
- 15
- Agreement rate
- 0.8
- Recorded readings
1.7 to 1.9 hours
- Numeric value
- 1.7
- Unit
- hours
- Source records
- 12
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 12 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d78d5d1-77b2-4da1-98d4-d9c36e743ce2 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f278f0d8-4062-420a-97c3-3a8b88253a08 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e2c9856-1836-49f0-9472-4dbeeb408f39 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6a9a800-889d-417f-b533-1913197d0022 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2344ae7a-c2f0-433b-9133-1dcb16bb18a0 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01962c67-e551-47b6-a276-e1ae1860d2a4 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab9b0d3d-4dab-4c5b-9c23-3a14f8fcfcde (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9502860d-0261-4d69-a4be-827a5376d356 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffaf9462-cdd8-433b-8b03-464a35577fe9 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:387d7f8d-9762-4f6b-99e1-bdc50b8a1633 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ed4e79-ad4c-426f-859d-83790c00439b (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The eli mination of octreotide from plas ma had an apparent half-life of 1.7 to 1.9 hours co m pared with 1 to 3 minutes with the natural hor mone.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:884e4287-a4d8-4a6e-8d99-dbe5e88875b9 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Elimination The elimination of octreotide from plasma had an apparent half-life of 1.7 to 1.9 hours compared with 1 to 3 minutes with the natural hormone.
3.2–4.5 hours
- Numeric value
- 3.2
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d80bc6-bdfb-4908-93e7-aace447c8d1a (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
In patients with acromegaly, elimination after chronic dosing was slightly slower than that seen in healthy volunteers, with mean apparent half-life values at steady state ranging from 3.2–4.5 hours across doses (20 mg, 40 mg, 60 mg, and 80 mg).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62a5e1eb-b48e-4ea6-8781-f75e490b17e4 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
In patients with acromegaly, elimination after chronic dosing was slightly slower than that seen in healthy volunteers, with mean apparent half-life values at steady state ranging from 3.2–4.5 hours across doses (20 mg, 40 mg, 60 mg, and 80 mg).
1.7 hours
- Numeric value
- 1.7
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9739ea6-74de-4a41-a806-6e827a23cedb (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
The elimination of octreotide from plasma had an apparent half-life of 1.7 hours, compared with the 1 to 3 minutes with the natural hormone, somatostatin.
Projected row 1114
- Medicine slug
- octreotide
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 17
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
1.67–2.5 hours
- Numeric value
- 1.67
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d80bc6-bdfb-4908-93e7-aace447c8d1a (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Absorption time was longer following oral administration compared to the subcutaneous route; peak concentrations were reached at a median of 1.67–2.5 hours after 20 mg MYCAPSSA administration compared to 0.5 hours for the subcutaneous administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62a5e1eb-b48e-4ea6-8781-f75e490b17e4 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Absorption time was longer following oral administration compared to the subcutaneous route; peak concentrations were reached at a median of 1.67–2.5 hours after 20 mg MYCAPSSA administration compared to 0.5 hours for the subcutaneous administration.
Projected row 1115
- Medicine slug
- octreotide
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 17
- Source count
- 15
- Agreement rate
- 0.933333
- Recorded readings
13.6 L
- Numeric value
- 13.6
- Unit
- L
- Source records
- 14
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 14 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d78d5d1-77b2-4da1-98d4-d9c36e743ce2 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f278f0d8-4062-420a-97c3-3a8b88253a08 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e2c9856-1836-49f0-9472-4dbeeb408f39 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6a9a800-889d-417f-b533-1913197d0022 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2344ae7a-c2f0-433b-9133-1dcb16bb18a0 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (Vdss) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01962c67-e551-47b6-a276-e1ae1860d2a4 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58d80bc6-bdfb-4908-93e7-aace447c8d1a (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution half-life (t α½ ) of octreotide acetate from plasma after subcutaneous administration was 0.2 h, the volume of distribution (Vdss) was estimated to be 13.6 L, and the total body clearance ranged from 7–10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62a5e1eb-b48e-4ea6-8781-f75e490b17e4 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution half-life (t α½ ) of octreotide acetate from plasma after subcutaneous administration was 0.2 h, the volume of distribution (Vdss) was estimated to be 13.6 L, and the total body clearance ranged from 7–10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab9b0d3d-4dab-4c5b-9c23-3a14f8fcfcde (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9739ea6-74de-4a41-a806-6e827a23cedb (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
In healthy volunteers, the distribution of octreotide from plasma was rapid (tα 1/2 = 0.2 h), the volume of distribution (Vdss) was estimated to be 13.6 L and the total body clearance was 10 L/h.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9502860d-0261-4d69-a4be-827a5376d356 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα1/2; = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffaf9462-cdd8-433b-8b03-464a35577fe9 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (Vdss) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:387d7f8d-9762-4f6b-99e1-bdc50b8a1633 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:884e4287-a4d8-4a6e-8d99-dbe5e88875b9 (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
Distribution In healthy volunteers, the distribution of octreotide from plasma was rapid (tα½ = 0.2 h), the volume of distribution (V dss ) was estimated to be 13.6 L, and the total body clearance ranged from 7 L/hr to 10 L/hr.
21.6 ± 8.5 L
- Numeric value
- 21.6
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ed4e79-ad4c-426f-859d-83790c00439b (opens source in a new tab)
Octreotide label
Version not recorded · Effective date not recorded
In patients with acromegaly, the volume of distribution (Vdss) was estimated to be 21.6 ± 8.5 L, and the total body clearance was increased to 18 L/h.
Projected row 1116
- Medicine slug
- odevixibat
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
2.36 hours
- Numeric value
- 2.36
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:151f1d3e-2bf4-47ce-b1be-a892de3258fa (opens source in a new tab)
Odevixibat label
Version not recorded · Effective date not recorded
Elimination Following a single oral dose of 7.2 mg odevixibat in healthy adults, the mean half-life (t 1/2 ) was 2.36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0935cd31-3251-4a0a-ac23-25ca4be12be9 (opens source in a new tab)
Odevixibat label
Version not recorded · Effective date not recorded
Elimination Following a single oral dose of 7.2 mg odevixibat in healthy adults, the mean half-life (t 1/2 ) was 2.36 hours.
Projected row 1117
- Medicine slug
- odevixibat
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
99%
- Numeric value
- 99
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:151f1d3e-2bf4-47ce-b1be-a892de3258fa (opens source in a new tab)
Odevixibat label
Version not recorded · Effective date not recorded
Distribution Human plasma protein binding of odevixibat is greater than 99% in vitro.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0935cd31-3251-4a0a-ac23-25ca4be12be9 (opens source in a new tab)
Odevixibat label
Version not recorded · Effective date not recorded
Distribution Human plasma protein binding of odevixibat is greater than 99% in vitro.
Projected row 1118
- Medicine slug
- ofloxacin
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 58
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
98%
- Numeric value
- 98
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c677b35c-0432-4ee5-af57-1f95449c48b6 (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
CLINICAL PHARMACOLOGY Following oral administration, the bioavailability of ofloxacin in the tablet formulation is approximately 98%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1779c568-d7bb-4bd5-bc29-13bd52ba8a0a (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
CLINICAL PHARMACOLOGY Following oral administration, the bioavailability of ofloxacin in the tablet formulation is approximately 98%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93ed9f70-b44f-496b-bdfc-c1bd5f1c260b (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
CLINICAL PHARMACOLOGY Following oral administration, the bioavailability of ofloxacin in the tablet formulation is approximately 98%.
Projected row 1119
- Medicine slug
- ofloxacin
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 58
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
9 hours
- Numeric value
- 9
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c677b35c-0432-4ee5-af57-1f95449c48b6 (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
Accumulation at steady-state can be estimated using a half-life of 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1779c568-d7bb-4bd5-bc29-13bd52ba8a0a (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
Accumulation at steady-state can be estimated using a half-life of 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93ed9f70-b44f-496b-bdfc-c1bd5f1c260b (opens source in a new tab)
Ofloxacin label
Version not recorded · Effective date not recorded
Accumulation at steady-state can be estimated using a half-life of 9 hours.
Projected row 1120
- Medicine slug
- olanzapine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 104
- Source count
- 104
- Agreement rate
- 0.990385
- Recorded readings
21 to 54 hours
- Numeric value
- 21
- Unit
- hours
- Source records
- 103
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 103 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d768cfe-3b20-4127-95b9-b4151b28afcc (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a279fe1-ed99-4a62-b2c7-831961470fa9 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cb1bebe-0ced-46d8-bf21-c28a9acc4a15 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e40d54bf-7334-4418-8a87-ff85941adec1 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7772a4c2-1fb1-412b-9e3b-ef3d693517a2 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c47f90fc-49fe-4f60-9da8-1365a1650dd9 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c745e2e-89d3-44d4-906e-704705c33310 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52bdaaaf-ab54-99d1-e063-6394a90a521f (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1705bab2-a2f8-4534-b1fc-eb309cd2696b (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a7300d3-95e3-427e-bf37-55fa654cc90a (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6f0b2e2-3cbd-4564-8b3e-f811589af275 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bded04a-d848-4ac6-b7c3-ff9b9fef3d29 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87b7fb23-c9b7-433f-bd17-cd3e91714c27 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dbe23f33-9e7d-49a7-8528-fa290661a96f (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:032e589c-47b1-4eb1-9466-8160297b81e9 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b418946a-1ab4-4d89-a012-d94fc361a3c4 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42d9ad47-52cc-ad11-e063-6394a90aedca (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed93d6b9-912a-444a-a695-439d0bfb877a (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce66d545-015b-41d5-80c3-964d78e36bfd (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88edb3fc-fcb6-4483-859d-f830b077aca2 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63bcfe98-d1fc-4cd7-9212-f59ee4dcc6d1 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:495efc49-7cdb-4b9e-e063-6394a90a547e (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d34f8f3-edc8-0a68-e063-6394a90a9c1f (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:028aa88e-fa50-7aa8-cc0b-97c0c9a0357c (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:024e8e9b-a4fc-4882-b080-c070467166a6 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22528ae1-e36f-48e1-e063-6294a90a3dd2 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54adae9e-6781-6a77-e063-6394a90ab5c8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:002dd00f-7946-ea4f-e063-6294a90a5916 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1387008-6dc4-4f1e-ae29-fa7a0f0be684 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ecbf540-572e-4ca4-b694-18ca1cd1c194 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76a6ff21-7157-4213-8073-35837a3ac07e (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:709d79a1-2742-4629-af43-161be166833a (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d1b83db-54db-d51f-e063-6394a90a4a69 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96165590-b287-0ed9-3723-752af59aedad (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ffcc56-63f9-4b12-a07a-c6177ffef5e8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3347d1c8-04c9-5ce1-8cda-b38e0412b709 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:979c3212-36e8-4287-aace-bef0875188d7 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:549dc142-adcd-99ed-e063-6294a90a37fa (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c47ee16f-5a86-49f2-8d85-5f49a6c8d91e (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5a9f78e-56f4-4249-800c-5f52a99fa84b (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cfc0f187-d3ff-4bbb-9129-0e94c6eda0ee (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df43938a-3469-40eb-8166-f0a2fd29d6d8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51b508ff-dc55-ff36-e063-6294a90a900f (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0943b4e-6bdc-48c1-8ecd-39cf732e16f5 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e830f488-c689-40f6-9351-f9c7454ff1ea (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4c525da-c2f6-b804-af49-601295922254 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9eb6b0d1-b301-4847-88f5-f8613d550ecc (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ba67321-6988-46ea-97a0-549954e2c405 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d349d5b7-5658-46d6-9bba-e6f6361cebb9 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6fd7ceb-1457-4c3e-9d30-4f658f39d37d (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a57a63e-f856-aafa-037a-c08f2fea6496 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fcec190f-b865-c5d3-e053-6394a90a7e45 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:325d5d69-5133-79ea-e063-6294a90afdd0 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9847a0e4-24fc-f4e8-e053-2995a90a961e (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d9f25d5-4513-434a-a37a-392a0c978f2e (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e095987-bdea-42f2-9550-c7155cf07d30 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e9666ef-4271-4834-8496-ccb3125d83db (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38a89689-efc2-4931-8f65-868dc0248d6a (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:636665be-9d7e-443a-8134-e8cc47e6ba24 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61424fa3-b09a-4267-a208-a7c7c3f69fe5 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6ec5610-b4a6-4646-954a-0fe8b1d3e143 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09e48e71-4dd2-4538-91d7-5b284f6647d8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58f175a8-5549-4f9e-baf4-8dc340c2cfd5 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1866a03c-eac9-44a1-8f33-7dc6e8a8c06a (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37c88965-c51d-946d-e063-6394a90a012c (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8626e68-088d-47ff-bf06-489a778815aa (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0d705bf-b719-4c7b-b83d-c17d41cbbfad (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e709eaf-4116-4ee3-8dff-ace36181d115 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1dfb4e7-4143-4422-b7a7-292e4fd75044 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52b99337-afa8-a6f9-e063-6294a90a2038 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e90e30c-78a1-486f-a13c-f1ff798216be (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d474d5a9-d338-511d-5823-567c0a1bbf4d (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d69af75-7615-4ec2-b7ef-467b2558c5c8 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4e41c2c-d32d-40c2-8afb-b6df998ba6b0 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10043041-a632-4e57-bc08-37216dea8546 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ed78a7d-4014-d280-e063-6294a90a8ee9 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:518a9400-edb8-6403-e063-6294a90a065d (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51b64b6d-4676-a637-e063-6394a90a450c (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55669a10-93f3-cfd6-e063-6294a90aa0e6 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad350abc-a1fc-4be4-b2be-c629121552a0 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68de2a51-69b2-4d99-be79-36a95a4bc475 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aff02cff-d079-bc82-6182-a24c4c6e09a6 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f4a2eaf-3a12-4ebe-b97f-0a7bfbc32572 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8586e828-34e7-4eb4-a933-6c688927478f (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcf8fcbf-636c-41ad-8084-c65ac2f117cc (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc56c264-d10e-4059-b0d5-2feff16b345d (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f485576-a4c4-45d4-816f-2e59fce9f517 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5 th to 95 th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5 th to 95 th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55668be2-62ac-3252-e063-6394a90a40f7 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea3259d5-36ee-4ac9-b849-9625626e2187 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c9963b1-c498-48a0-a3a1-1eaa6a1028fc (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3857220-d9ff-4820-bf53-f2384b59a1a6 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6077f5c4-01d7-4c1d-97a0-cb859f98ce68 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75616c31-8fed-4014-a9f2-4a028eccd586 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12ce860a-6f22-4db6-8acf-786b40f5a5a5 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40187874-447a-de20-e063-6394a90aafe7 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c44a96cc-817d-4eb5-a13a-00977f76e666 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e6b4e9-de26-16c3-e063-6294a90a7764 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e5ef52d-315b-4055-9e52-403e6f896f24 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b513823d-927c-4111-8766-e6c37f84b221 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ae07ad4-4e58-4740-9f02-035ec061fefc (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30 hr), and apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile; mean of 25 L/hr).
30 hours
- Numeric value
- 30
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11544cba-64a9-49cb-8d74-da228053b252 (opens source in a new tab)
Olanzapine label
Version not recorded · Effective date not recorded
The effective half-life for olanzapine after intramuscular ZYPREXA RELPREVV administration is approximately 30 days as compared to a half-life after oral administration of approximately 30 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1110Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.